HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-12-07FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) submitted by Gi…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: PK of Efavirenz & Lopinavir Nano-formulations in Healthy Volunteers [Phase 1]
Phase 1 study assessing the pharmacokinetics of nano-formulated efavirenz and lopinavir in healthy volunteers has been suspended.
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia [NA]
This clinical trial investigated adding raltegravir to ongoing antiretroviral therapy in patients with low-level HIV viremia; the study is c…
-
CLINICAL_TRIALS approval · 2016-11-30Clinical Trial Update: Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Tipranavir has received marketing approval for HIV infection in patients with progressive systemic HIV-1 disease who have failed or are into…
-
CLINICAL_TRIALS approval · 2016-11-30Clinical Trial Update: Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Tipranavir has been approved for marketing for HIV-1 infection in protease inhibitor-experienced patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF [Phase 3]
Phase 3 switch study evaluating F/TAF in HIV-1 patients virologically suppressed on regimens containing FTC/TDF has completed with results p…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Folinic Acid: Supplementation and Therapy [Phase 3]
The document reports the completion of a Phase 3 trial evaluating folinic acid supplementation and therapy in individuals with HIV infection…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: The PreNAPS Study: FI, Nutrition, and Psychosocial Health Outcomes at Gulu Regional Referral Hospital
The PreNAPS study at Gulu Regional Referral Hospital completed, evaluating food insecurity, nutrition, and psychosocial health outcomes in p…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds [Phase 4]
Phase 4 trial update evaluating interferon alfa sensitivity in HIV/Hepatitis C–coinfected individuals before and after initiation of HIV the…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: An HIV Intervention for Black Men at Risk - The Enhanced Sexual Health Intervention for Men (ES-HIM) [Phase 2]
Phase 2 results update for ES-HIM, a behavioral intervention to improve sexual health among Black men at risk for HIV.
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events [Phase 4]
Phase 4 trial examining whether immediate initiation of antiretroviral therapy improves outcomes compared with deferring treatment in HIV-in…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Mothers Living With HIV and Their Adolescent Children [NA]
This entry notes a completed clinical trial sponsored by UCLA investigating mothers living with HIV and how it affects family relations, men…
-
CLINICAL_TRIALS research · 2016-11-28Clinical Trial Update: A Parenting and Self-Care Intervention for HIV Infected Mothers [NA]
Update on a parenting and self-care intervention trial for HIV-infected mothers; the study has completed.
-
FDA approval · 2016-11-22FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for NORVIR (ritonavir) submitted by AbbVie.
-
FDA approval · 2016-11-22FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie's AbbVie Inc.
-
FDA approval · 2016-11-22FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie, updating the product labeling as a result of the subm…
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine
This is a completed clinical trial update. It evaluates fluoride metabolism, bone remodeling, and bone mineral density in HIV-infected patie…
-
FDA approval · 2016-11-21FDA Approved: LAMIVUDINE — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original ANDA for lamivudine, enabling a generic version of lamivudine to be marketed.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine [Phase 1]
A Phase 1 trial evaluating safety and immunogenicity of an oral replicating Ad26-vectored HIV-1 vaccine has completed.
-
FDA approval · 2016-11-21FDA Approved: LAMIVUDINE — Original Application (Ingenus Pharmaceuticals, LLC)
The FDA approved a generic lamivudine product under an Original Application filed by Ingenus Pharmaceuticals, LLC.
-
FDA approval · 2016-11-21FDA Approved: LAMIVUDINE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original generic application for lamivudine from Rising Pharma Holdings, Inc., making a generic option available for HIV-1 …
-
CLINICAL_TRIALS research · 2016-11-15Clinical Trial Update: Treatment With Probiotics (Saccharomyces Boulardii) and Its Role in Bacterial Translocation and Immune Reconstitution in VIH Infection. [Phase 2]
A Phase 2 clinical trial update examines using the probiotic Saccharomyces boulardii to influence bacterial translocation and immune reconst…
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: AIMS Study: Improving HIV Treatment Adherence [NA]
The HIV treatment adherence trial 'AIMS' sponsored by Wageningen University has completed.
-
CLINICAL_TRIALS research · 2016-11-11Clinical Trial Update: Cognition Metabolism and Exercise Among Women Living With HIV in Puerto Rico [NA]
Clinical trial investigating cognition, metabolism, and exercise among women living with HIV in Puerto Rico.
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo [Phase 1, Phase 2]
This document reports an update on a Phase 1/2 trial evaluating the safety and immunogenicity of the DNA-GTU vaccine in HIV-infected adults …